NCT06100016View on ClinicalTrials.gov

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

RecruitingOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

December 1, 2025

Conditions
Colorectal CancerOrganoids
Trial Locations (1)

110001

RECRUITING

Phase I Clinical Trials Center Of The First Hospital of China Medical University, Shenyang

Sponsors
All Listed Sponsors
collaborator

Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

UNKNOWN

collaborator

Precedo Pharmaceuticals Co. Ltd.

UNKNOWN

collaborator

Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China

UNKNOWN

lead

Funan Liu

OTHER